BioCryst Pharmaceuticals, Inc. (BCRX) financial statements (2021 and earlier)

Company profile

Business Address 4505 EMPEROR BOULEVARD
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments300136104114555273
Cash and cash equivalents2721142750222955
Short-term investments28227864332318
Restricted cash and investments2223220
Receivables8224696 
Inventory, net of allowances, customer advances and progress billings7 2 121
Inventory7 2 121
Deferred costs  00000
Other undisclosed current assets64211516
Total current assets:324164114125676689
Noncurrent Assets
Property, plant and equipment779101050
Long-term investments and receivables  224194841
Long-term investments  224194841
Other noncurrent assets4412456
Other undisclosed noncurrent assets    000
Total noncurrent assets:11113253235948
TOTAL ASSETS:33517514717890125137
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities74503631243223
Accounts payable191486493
Accrued liabilities34211613111612
Employee-related liabilities      2
Taxes payable      0
Interest and dividends payable22151212976
Deferred revenue02
Debt31403435283030
Deferred revenue and credits82  
Other undisclosed current liabilities  0  25
Total current liabilities:106926975546458
Noncurrent Liabilities
Long-term debt and lease obligation1243     
Long-term debt, excluding current maturities120      
Finance lease, liability43
Liabilities, other than long-term debt  008104
Deferred revenue and credits08104
Deferred rent credit  0
Total noncurrent liabilities:1243008104
Total liabilities:229967075637461
Stockholders' equity
Stockholders' equity attributable to parent(19)38498424876
Common stock2211111
Additional paid in capital1,002877780715567558543
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)(0)
Accumulated deficit(1,023)(841)(732)(632)(566)(511)(468)
Total stockholders' equity:(19)38498424876
Other undisclosed liabilities and equity125412820252 
TOTAL LIABILITIES AND EQUITY:33517514717890125137

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues18492125264814
Revenue, net25264814
Cost of revenue(2)(4) (1)(2)(1) 
Cost of goods and services sold(2)(4) (1)(2)(1) 
Gross profit:16452124244714
Operating expenses(191)(145)(115)(81)(73)(86)(60)
Other undisclosed operating income      0
Operating loss:(175)(99)(94)(57)(49)(39)(46)
Interest and debt expense(17)(12)(9)(9)(6)(5)(5)
Other undisclosed income from continuing operations before equity method investments, income taxes8      
Loss from continuing operations before income taxes:(183)(111)(103)(66)(55)(45)(51)
Income tax expense      (17)
Net loss:(183)(111)(103)(66)(55)(45)(68)
Other undisclosed net income (loss) attributable to parent 220(0)223
Net loss available to common stockholders, diluted:(183)(109)(101)(66)(55)(43)(45)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(183)(111)(103)(66)(55)(45)(68)
Other comprehensive income (loss)(0)0(0)(0)0(0)(0)
Comprehensive loss:(183)(111)(103)(66)(55)(45)(68)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 220(0)223
Comprehensive loss, net of tax, attributable to parent:(183)(109)(101)(66)(55)(43)(45)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: